232 related articles for article (PubMed ID: 2648146)
1. A comparison of childhood and adult type I diabetes mellitus.
Karjalainen J; Salmela P; Ilonen J; Surcel HM; Knip M
N Engl J Med; 1989 Apr; 320(14):881-6. PubMed ID: 2648146
[TBL] [Abstract][Full Text] [Related]
2. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
3. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
4. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of type 1 diabetes at onset in children: results from the French Incidence Study.
Levy-Marchal C; Czernichow P
Diabete Metab; 1993; 19(3):296-303. PubMed ID: 8405620
[TBL] [Abstract][Full Text] [Related]
6. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
7. [Clinical heterogeneity of childhood diabetes in Baranya county].
Makovi H; Soltész G; Hermann R
Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
[TBL] [Abstract][Full Text] [Related]
8. [Insulin autoantibodies and islet cell antibodies in recently appearing diabetes mellitus type I. Association with age of manifestation and HLA phenotype].
Ziegler AG; Rabl W; Albert E; Standl E
Dtsch Med Wochenschr; 1991 Nov; 116(46):1737-41. PubMed ID: 1935660
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
10. The genetics of Type 1 (insulin-dependent) diabetes.
Cudworth AG; Wolf E
Curr Probl Clin Biochem; 1983; 12():45-64. PubMed ID: 6418443
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
12. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
13. [Etiology and pathogenesis of insulin-dependent diabetes mellitus].
Klöppel G; Clemens A
Verh Dtsch Ges Pathol; 1996; 80():93-103. PubMed ID: 9065059
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
[TBL] [Abstract][Full Text] [Related]
15. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
17. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.
Riley WJ; Maclaren NK; Krischer J; Spillar RP; Silverstein JH; Schatz DA; Schwartz S; Malone J; Shah S; Vadheim C
N Engl J Med; 1990 Oct; 323(17):1167-72. PubMed ID: 2215594
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]